Vimarsana
Biggest News Aggregation in the World

Chris Waddick News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Chris Waddick. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Chris Waddick Today - Breaking & Trending Today

Cardiol Therapeutics : MATERIAL CHANGE REPORT - Form 6-K -October 11, 2023 at 10:03 am EDT - Vimarsana News

Cardiol Therapeutics : MATERIAL CHANGE REPORT - Form 6-K -October 11, 2023 at 10:03 am EDT

MATERIAL CHANGE REPORT - Name and Address of Company Cardiol Therapeutics Inc. 2265 Upper Middle Road East, Suite 602 Oakville, Ontario,...

Cardiol Therapeutics : MATERIAL CHANGE REPORT - Form 6-K -September 20, 2023 at 10:03 am EDT - Vimarsana News

Cardiol Therapeutics : MATERIAL CHANGE REPORT - Form 6-K -September 20, 2023 at 10:03 am EDT

MATERIAL CHANGE REPORT - Name and Address of Company Cardiol Therapeutics Inc. 2265 Upper Middle Road East, Suite 602 Oakville, Ontario,...

Cardiol Therapeutics Inc.: Cardiol Therapeutics Announces Year-End 2022 Update on Operations - Vimarsana News

Cardiol Therapeutics Inc.: Cardiol Therapeutics Announces Year-End 2022 Update on Operations

Initiated patient enrollment in a Phase II open-label clinical trial investigating the safety, tolerability, and efficacy of CardiolRx in patients with recurrent pericarditis - a debilitating heart disease

Cardiol Therapeutics Announces Year-End 2022 Update on Operations - Vimarsana News

Cardiol Therapeutics Announces Year-End 2022 Update on Operations

Cardiol Therapeutics Inc. , a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart... | March 29, 2023

Cardiol Therapeutics Inc.: Cardiol Therapeutics Reports Results of 2022 Annual General Meeting - Vimarsana News

Cardiol Therapeutics Inc.: Cardiol Therapeutics Reports Results of 2022 Annual General Meeting

Oakville, Ontario--(Newsfile Corp. - June 29, 2022) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on the research